Journal
EXPERT OPINION ON THERAPEUTIC TARGETS
Volume 20, Issue 8, Pages 903-906Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/14728222.2016.1159676
Keywords
Androgen receptor; splice variants; prostate cancer; drug resistance
Categories
Funding
- NCI NIH HHS [P50 CA090381, P01 CA163227, P50 CA097186] Funding Source: Medline
- BLRD VA [I01 BX000585, I01 BX003324] Funding Source: Medline
- VA [5I01BX000585-03, 549385] Funding Source: Federal RePORTER